このアイテムのアクセス数: 371

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
16_0738.pdf459.9 kBAdobe PDF見る/開く
タイトル: 膀胱腫瘍の再発に対するβ-glucuronidase阻害剤(SLA)の効果
その他のタイトル: Preventive effect of beta-glucuronidase inhibitor (SLA) on recurrence of the bladder tumor
著者: 宮川, 美栄子  KAKEN_name
原田, 卓  KAKEN_name
吉田, 修  KAKEN_name
加藤, 篤二  KAKEN_name
著者名の別形: Miyakawa, Mieko
Harada, Takashi
Yoshida, Osamu
Kato, Tokuji
キーワード: Acetates/therapeutic use
Adipic Acids/therapeutic use
Aged
Female
Glucuronidase/antagonists & inhibitors
Humans
Lactones/therapeutic use
Male
Middle Aged
Neoplasm Recurrence, Local/prevention & control
Urinary Bladder Neoplasms/prevention & control
発行日: Dec-1970
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 16
号: 12
開始ページ: 738
終了ページ: 744
抄録: Thirty-one patients with pedunculated, non-infiltrative tumor of the bladder was continuously administered SLA, beta-glucuronidase inhibitor, after surgery. The recurrence rate of the SLA-treatment group was 12.9 % within six months, 38.1 % within one year, 50.0 % within two year, and 81.8 % within three year. This result was compared with the recurrence rate of the non-prevention group in the preceding paper. Within the first two years, the recurrence rate was always lower in the SLA-group though not so significantly by statistical analysis. Some cases obviously showed the preventive effect of SLA against recurrence of tumor of the bladder. One patient complained of anorexia and nausea due to SLA, which was discontinued after two months administration.
URI: http://hdl.handle.net/2433/121208
PubMed ID: 5531642
出現コレクション:Vol.16 No.12

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。